BDRX Shares Dive 14%: What Regulatory Hurdles Mean for Biodexa’s Future
BDRX shares plunge 14.25% as investors await regulatory news – find out what could reverse the drop and unlock value for Biodexa Pharma.
- BIODEXA PHARMACEUTICALS
- United Kingdom
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read